Fortrea Income Statement
FTRE / Health Care|5 years of annual SEC 10-K data (FY2021-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 5 fiscal years. All figures from audited SEC 10-K filings.
Fortrea reported $2.7B in revenue and $986M in net loss for FY2025. Revenue has declined at a 2.9% compound annual rate over the past 4 years.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -0.32 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $2.7B | $2.7B | $2.8B | $2.8B | $3.1B |
| SG&A Expense | $456.4M | $560.7M | $448.1M | $416.1M | $303.1M |
| Operating Income | -$872.6M | -$161.9M | $32.0M | $187.1M | $114.3M |
| Interest Expense | - | - | $69.8M | -$200.0K | $200.0K |
| Income Tax | $3.2M | -$3.5M | $1.2M | $41.1M | $38.4M |
| Net Income | -$986.2M | -$328.5M | -$25.2M | $186.2M | $98.0M |
| EPS (Basic) | -$10.81 | -$3.67 | $1.10 | $2.09 | $1.10 |
| EPS (Diluted) | -$10.81 | -$3.67 | $1.10 | $2.09 | $1.10 |
| Shares Outstanding | 93.1M | 89.7M | 0 | 88.8M | 88.8M |
| Operating Margin | -32.0% | -6.0% | 1.1% | 6.6% | 3.7% |
| Profit Margin | -36.2% | -12.2% | -0.9% | 6.6% | 3.2% |